Author:
Wang Chao,Wang Ming-da,Cheng Peng,Huang Hai,Dong Wei,Zhang Wei-wei,Li Peng-peng,Lin Chuan,Pan Ze-ya,Wu Meng-chao,Zhou Wei-ping
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference47 articles.
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.
2. Pinato DJ, Sharma R, Allara E, Yen C, Arizumi T, Kubota K et al. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol 2016; pii: 0168-8278(16)30535-9.
3. Su C, Lin Y, Cai L, Mao Q, Niu J . Association between mannose-binding lectin variants, haplotypes and risk of hepatocellular carcinoma: a case-control study. Sci Rep 2016; 6: 32147.
4. Huang P, Zhuang B, Zhang H, Yan H, Xiao Z, Li W et al. Hepatitis B virus X protein (HBx) is responsible for resistance to targeted therapies in hepatocellular carcinoma: ex vivo culture evidence. Clin Cancer Res 2015; 21: 4420–4430.
5. Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L et al. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice. Hepatology 2012; 55: 108–120.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献